Elicera Therapeutics
G├╢teborg
About Elicera Therapeutics
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.8M
- Funding stage: IPO
- Last round: Grant (Feb 2025)
- Ticker: sto:ELIC
- Website: elicera.com
- Phone: [email protected]
Industries & Categories
Life Science, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/elicera-therapeutics-48483 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.